BRISTOL MYERS SQUIBB
Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.
BRISTOL MYERS SQUIBB
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1887-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.bms.com
Total Employee:
10001+
Status:
Active
Contact:
(212)546-4000
Total Funding:
6.08 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag Nginx
Similar Organizations
AccendoWave
AccendoWave provides discomfort detection, monitoring, and reporting devices for the reduction of human suffering.
AmerisourceBergen
AmerisourceBergen provides pharmaceutical supply chain distribution & pharmacy management solutions.
Bartell Drugs
Bartell Drugs is the oldest family owned drugstore chain in the USA.
Dohmen Life Science Service
Intelligent outsourcing for drug and device manufacturers.
Eli Lilly
Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
G. D. Searle
G. D. Searle, LLC is a research-based pharmaceutical company that manufactures and markets prescription pharmaceuticals and other
Gilead Science Korea
Gilead Science Korea is engaged in medical, licensing, marketing, and sales activities.
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Johnson & Johnson
Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
KNMP
KNMP is the Royal Dutch Society for the Promotion of Pharmacy is the umbrella professional and branch organization of pharmacists.
Laboratoires Genevrier
Laboratoires Genevrier engages in improving human health by offering an extensive range of innovative and effective pharmaceutical products.
Mayinglong
Mayinglong Pharmaceutical Group manufactures and markets pharmaceutical products.
Medical Products Laboratories
Medical Products is into research, development, manufacturing and distribution of innovative products to our customers.
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Merck
Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.
ONO Pharmaceutical
ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents.
Orajel
Orajel engages in the manufacture and marketing of cosmetics and over-the-counter pharmaceuticals.
Pfizer
Pfizer provides access to safe and effective and affordable medicines and health care services.
Pleasant Valley Fund
Pleasant Valley Fund LLC is an early and seed stage investment fund focused on mobile, data, health, biomedical and pharma verticals.
Roxane Laboratories
Roxane Laboratories engages in the research, development, manufacture, marketing, sale, and distribution of generic pharmaceuticals.
Shionogi
Shionogi supply the best possible medicine to protect the health and wellbeing of the patients they serve.
Sustained Nano Systems
Sustained Nano Systems is a provider of nanoparticle-based drug delivery technology.
Syndel
For more than 40 years, Syndel has been a leader in developing high quality aquaculture pharmaceutical health and nutritional products.
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a pharmaceutical company specializing in the development, production and marketing of generic.
University of California, San Francisco
Director of the Lab for Advanced Cytometry (LAC) and the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine
Walgreens
Walgreens is a pharmacy, health, and wellness service center that offers trained infusion nurses and pharmacists to treat patients.
WEPA APOTHEKENBEDARF GmbH & Co KG
WEPA APOTHEKENBEDARF GmbH & Co KG distributes healthcare, laboratory, and formulation equipment and products for pharmacies.
Yliopiston Apteekki
Yliopiston Apteekki is an online store that offers a wide range of medicine, cosmetics, vitamins and nutritional supplements.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-06-03 | Turning Point Therapeutics | Turning Point Therapeutics acquired by Bristol Myers Squibb | 4.1 B USD |
| 2020-10-05 | MyoKardia | MyoKardia acquired by Bristol Myers Squibb | 13.1 B USD |
| 2020-08-24 | Forbius | Forbius acquired by Bristol Myers Squibb | N/A |
| 2019-11-20 | Celgene | Celgene acquired by Bristol Myers Squibb | N/A |
| 2019-01-03 | Celgene | Celgene acquired by Bristol Myers Squibb | 74 B USD |
| 2017-08-03 | IFM Therapeutics | IFM Therapeutics acquired by Bristol Myers Squibb | N/A |
| 2016-07-05 | Cormorant Pharmaceuticals | Cormorant Pharmaceuticals acquired by Bristol Myers Squibb | N/A |
| 2016-03-23 | Padlock Therapeutics | Padlock Therapeutics acquired by Bristol Myers Squibb | 600 M USD |
| 2015-11-02 | Cardioxyl Pharmaceuticals | Cardioxyl Pharmaceuticals acquired by Bristol Myers Squibb | 2 B USD |
| 2015-02-23 | Flexus Biosciences | Flexus Biosciences acquired by Bristol Myers Squibb | 1.25 B USD |
Investors List
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Bristol Myers Squibb
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Post-IPO Equity - Bristol Myers Squibb
Aperture Venture Partners
Aperture Venture Partners investment in Post-IPO Equity - Bristol Myers Squibb
Greg Bailey
Greg Bailey investment in Post-IPO Equity - Bristol Myers Squibb
Connecticut Innovations
Connecticut Innovations investment in Post-IPO Equity - Bristol Myers Squibb
Knoll Capital Management
Knoll Capital Management investment in Post-IPO Equity - Bristol Myers Squibb
Vivo Capital
Vivo Capital investment in Post-IPO Equity - Bristol Myers Squibb
Venrock
Venrock investment in Post-IPO Equity - Bristol Myers Squibb
Litmore Capital
Litmore Capital investment in Post-IPO Equity - Bristol Myers Squibb
Carl Icahn
Carl Icahn investment in Post-IPO Equity - Bristol Myers Squibb
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-08 | Autobahn Therapeutics | Bristol Myers Squibb investment in Venture Round - Autobahn Therapeutics | 32.7 M USD |
| 2022-09-06 | ArsenalBio | Bristol Myers Squibb investment in Series B - ArsenalBio | 220 M USD |
| 2022-08-25 | Aktis Oncology | Bristol Myers Squibb investment in Series A - Aktis Oncology | 84 M USD |
| 2022-07-20 | BigHat Biosciences | Bristol Myers Squibb investment in Series B - BigHat Biosciences | 75 M USD |
| 2022-06-08 | Owkin | Bristol Myers Squibb investment in Series B - Owkin | 50 M USD |
| 2022-06-02 | Transition Bio | Bristol Myers Squibb investment in Series A - Transition Bio | 50 M USD |
| 2022-05-31 | Sapience Therapeutics | Bristol Myers Squibb investment in Series B - Sapience Therapeutics | 41 M USD |
| 2022-05-11 | Nuvig Therapeutics | Bristol Myers Squibb investment in Series A - Nuvig Therapeutics | 47 M USD |
| 2022-04-28 | Octant Bio | Bristol Myers Squibb investment in Series B - Octant Bio | 80 M USD |
| 2022-04-14 | Be Biopharma | Bristol Myers Squibb investment in Series B - Be Biopharma | 130 M USD |
Newest Events participated
Participated in Nordic life science Days 2017
on 2017-09-12 as sponsor
Participated in Fast Company Innovation Festival
on 2016-11-09 as sponsor
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-20 | Novartis-backed ImmPACT Bio snags $111M and new CEO as cancer CAR-T yields phase 1 results |
Official Site Inspections
http://www.bms.com Semrush global rank: 106.06 K Semrush visits lastest month: 919.04 K
- Host name: 45.60.150.161
- IP address: 45.60.150.161
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Bristol Myers Squibb"
Our leadership team - Bristol Myers Squibb
Meet the executive leaders at Bristol Myers Squibb who are not only responsible for day-to-day operations, but are also innovators in the biotech industry committed to patients, customers, employees, community and stockholders.See details»
Corporate governance and management - Bristol Myers Squibb
Find out about Bristol Myers Squibb's corporate governance, which ensures the company operates in the most reliable, efficient, transparent and ethical manner.See details»
Global Biopharmaceutical Company
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.See details»
Our company: Industry leadership in BioPharma - Bristol Myers …
Learn more about Bristol Myers Squibb, a global biopharma company dedicated to discover, develop and deliver innovative medicines to patients with serious diseases.See details»
Bristol Myers Squibb - Wikipedia
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [2] BMS is one of the world's largest pharmaceutical …See details»
Login - myBMS
Secure login portal for Bristol Myers Squibb employees to access company resources.See details»
People and business resource groups - Bristol Myers Squibb
Read about our People and Business Resource Groups (PBRGs) at Bristol Myers Squibb that focus on sustaining a culture of diversity and inclusion to achieve our patient-focused mission …See details»
Bristol-Myers Squibb Org Chart + Executive Team
The org chart of Bristol-Myers Squibb contains its 180 main executives like Christopher Boerner, David Elkins and Greg Meyers.See details»
Bristol Myers-Squibb - Our mission and our …
To our patients and customers We commit to scientific excellence and investment in biopharmaceutical research and development to provide innovative, high-quality medicines that address the …See details»
2024 Impact Report - Bristol Myers Squibb
Explore Bristol Myers Squibb's 2024 Impact Report to discover our commitment to environmental, social and governance practices. Learn about our progress, initiatives and future …See details»
Bristol-Myers Squibb Announces Post-Closing Leadership Team
Jun 5, 2019 Samit Hirawat, M.D., will join Bristol-Myers Squibb as the Chief Medical Officer, Global Drug Development, leading the development organization across therapeutic areas. …See details»
BMS Careers
Discover what it means to have a meaningful career. At Bristol Myers Squibb, you'll transform patients' lives and help them prevail over serious diseases.See details»
Bristol Myers-Squibb - People - globalcitizens.bms.com
Making A Difference Behind everything we do is a human network of thousands of people around the world working tirelessly to help bring transformational medicines to patients facing serious …See details»
Bristol Myers Squibb - Global Health Progress
Learn more about BMS. The Bristol Myers Squibb Foundation The Bristol Myers Squibb Foundation, an independent charitable organization, focuses on communities most at risk of …See details»
Bristol Myers Squibb - 2019 Annual Report - PBRG
Bristol Myers Squibb Network of Women (B-NOW) Partnered with/sponsored professional development activities for BMS women in the U.S. and E.U. to help prepare them for …See details»
The power of inclusion - Bristol Myers Squibb
Learn more about BMS’ commitment to diversity and inclusion and how our People, Business and Resource Groups (PBRGs) help inform key business decisions and enhance our global patient …See details»
Annual Report 2021 - Bristol Myers Squibb
At Bristol Myers Squibb, valuing diverse perspectives is deliberate, and strengthening a culture of inclusion is intentional. Our global People & Business Resource Groups (PBRGs) are aligned …See details»
Learn Why Two Science Leaders Who Left BMS Were Inspired to …
Dec 19, 2024 Delivering groundbreaking treatments and doing transformative work. That’s what motivated two scientists who had worked for BMS to return after pursuing opportunities …See details»
Bristol Myers Squibb CEO calls for policy certainty in U.S. - STAT
6 days ago Bristol Myers Squibb CEO warns against “slashing U.S. investment in medicines or importing lackluster policies of less innovative health care systems.”See details»
Bristol Myers Squibb - Bristol Myers Squibb Reports First Quarter ...
Apr 24, 2025 Financial Guidance Bristol Myers Squibb is raising key 2025 non-GAAP line-item guidance assumptions as outlined below. The company is increasing its full-year revenue …See details»